Search Results - Christopher P Denton

Refine Results
  1. 1

    News and failures from recent treatment trials in systemic sclerosis by Christopher P. Denton, Philip Yee, Voon H. Ong

    Published in European Journal of Rheumatology (2020-10-01)
    Get full text
    Article


  2. 2

    Recent developments in connective tissue disease associated pulmonary arterial hypertension by Stefano Rodolfi, Voon H. Ong, Christopher P. Denton

    Get full text
    Article


  3. 3

    Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma Skin. by Joanna Nikitorowicz-Buniak, Christopher P Denton, David Abraham, Richard Stratton

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  4. 4

    Systemic Sclerosis by Michael Hughes, Yannick Allanore, Christopher P. Denton, Marco Matucci-Cerinic

    Published in European Medical Journal Rheumatology (2020-07-01)
    Get full text
    Article


  5. 5

    How do doctors and patients communicate about the treatment of systemic sclerosis-associated interstitial lung disease? A plain language summary of publication by Masataka Kuwana, Aiko Saito, Sue Farrington, Ilaria Galetti, Christopher P. Denton, Dinesh Khanna

    Get full text
    Article


  6. 6

    Nailfold capillaroscopy in patients with systemic sclerosis-associated interstitial lung disease: a substudy of the SENSCIS trial by Vanessa Smith, Maurizio Cutolo, Christopher P Denton, Ariane L Herrick, Margarida Alves, Carina Ittrich

    Published in RMD Open (2025-10-01)
    Get full text
    Article


  7. 7

    Impact of Scleroderma‐Associated Autoantibodies on Clinical Outcome Assessments: Post Hoc Analysis From a Randomised, Double‐blind, Placebo‐controlled, Phase 3 Trial of Tocilizumab... by Basmah Al Dulaijan, Suiyuan Huang, Celia J. F. Lin, Christopher P. Denton, Dinesh Khanna

    Published in ACR Open Rheumatology (2025-01-01)
    Get full text
    Article


  8. 8

    The senescence-like activity of BMS-470539 is associated with anti-fibrotic actions in models of dermal fibrosis by Camilla SA Davan-Wetton, Natalya Khodeneva, Christopher P. Denton, David J. Abraham, Mauro Perretti, Trinidad Montero-Melendez

    Published in Arthritis Research & Therapy (2025-09-01)
    Get full text
    Article


  9. 9

    Characterization of a pathogenic nonmigratory fibroblast population in systemic sclerosis skin by Kristina E.N. Clark, Shiwen Xu, Moustafa Attar, Voon H. Ong, Christopher D. Buckley, Christopher P. Denton

    Published in JCI Insight (2025-05-01)
    Get full text
    Article


  10. 10

    Reduced exercise capacity in patients with systemic sclerosis is associated with lower peak tissue oxygen extraction: a cardiovascular magnetic resonance-augmented cardiopulmonary... by James T. Brown, Tushar Kotecha, Jennifer A. Steeden, Marianna Fontana, Christopher P. Denton, J. Gerry Coghlan, Daniel S. Knight, Vivek Muthurangu

    Get full text
    Article


  11. 11

    Dysregulated B cell function and disease pathogenesis in systemic sclerosis by Claire F. Beesley, Nina R. Goldman, Taher E. Taher, Christopher P. Denton, David J. Abraham, Rizgar A. Mageed, Voon H. Ong

    Published in Frontiers in Immunology (2023-01-01)
    Get full text
    Article


  12. 12

    Single-Cell Analysis of ADSC Interactions with Fibroblasts and Endothelial Cells in Scleroderma Skin by Marvin L. Frommer, Benjamin J. Langridge, Laura Awad, Sara Jasionowska, Christopher P. Denton, David J. Abraham, Jeries Abu-Hanna, Peter E. M. Butler

    Published in Cells (2023-07-01)
    Get full text
    Article


  13. 13

    Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis by Elizabeth R. Volkmann, Christopher P. Denton, Martin Kolb, Marlies S. Wijsenbeek-Lourens, Claire Emson, Krischan Hudson, Anthony J. Amatucci, Oliver Distler, Yannick Allanore, Dinesh Khanna

    Published in European Respiratory Review (2024-06-01)
    Get full text
    Article


  14. 14

    Exploring Anti-Fibrotic Effects of Adipose-Derived Stem Cells: Transcriptome Analysis upon Fibrotic, Inflammatory, and Hypoxic Conditioning by Marvin L. Frommer, Benjamin J. Langridge, Alexandra Beedie, Sara Jasionowska, Laura Awad, Christopher P. Denton, David J. Abraham, Jeries Abu-Hanna, Peter E. M. Butler

    Published in Cells (2024-04-01)
    Get full text
    Article


  15. 15

    Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study by Panagiota Xanthouli, Paul Uesbeck, Hanns-Martin Lorenz, Norbert Blank, Christina A. Eichstaedt, Satenik Harutyunova, Benjamin Egenlauf, Jerry G. Coghlan, Christopher P. Denton, Ekkehard Grünig, Nicola Benjamin

    Published in Arthritis Research & Therapy (2024-07-01)
    Get full text
    Article


  16. 16

    Induction of Pro-Fibrotic CLIC4 in Dermal Fibroblasts by TGF-β/Wnt3a Is Mediated by GLI2 Upregulation by Christopher W. Wasson, Begoña Caballero-Ruiz, Justin Gillespie, Emma Derrett-Smith, Jamel Mankouri, Christopher P. Denton, Gianluca Canettieri, Natalia A. Riobo-Del Galdo, Francesco Del Galdo

    Published in Cells (2022-02-01)
    Get full text
    Article


  17. 17

    NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertension by Ioannis Papaioannou, Athina Dritsoula, Ping Kang, Reshma S. Baliga, Sarah L. Trinder, Emma Cook, Xu Shiwen, Adrian J. Hobbs, Christopher P. Denton, David J. Abraham, Markella Ponticos

    Published in JCI Insight (2024-06-01)
    Get full text
    Article


  18. 18

    Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial by Peter Saunders, Vicky Tsipouri, Gregory J. Keir, Deborah Ashby, Marcus D. Flather, Helen Parfrey, Daphne Babalis, Elisabetta A. Renzoni, Christopher P. Denton, Athol U. Wells, Toby M. Maher

    Published in Trials (2017-06-01)
    Get full text
    Article


  19. 19

    Comparative Efficacy of Immunosuppressive Therapies in the Treatment of Diffuse Cutaneous Systemic Sclerosis by Barbara White, Daniel E. Furst, Tracy M. Frech, Masataka Kuwana, Laura Hummers, Wendy Stevens, Suzanne Kafaja, Eun Bong Lee, Oliver Distler, Dinesh Khanna, Christopher P. Denton, Robert Spiera, for the RESOLVE‐1 investigators

    Published in ACR Open Rheumatology (2025-03-01)
    Get full text
    Article


  20. 20

    Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trial by Edward P. Stern, Lauren V. Host, Ivy Wanjiku, K. Jane Escott, Peter S. Gilmour, Rachel Ochiel, Robert Unwin, Aine Burns, Voon H. Ong, Helen Cadiou, Aidan G. O’Keeffe, Christopher P. Denton

    Published in Arthritis Research & Therapy (2022-06-01)
    Get full text
    Article


Search Tools: